Other News

Around 9.1 million people in Europe have dementia and these numbers are expected to increase to 14 million people by 2040, due to the ageing of European societies. With no disease-modifying treatment currently available and varied access to diagnosis, treatment and high quality care across Member States, EU institutions must show leadership by making dementia a priority in the fields of health, research and innovation, and social affairs.

Stress reduction of patients undergoing surgical interventions

Aiming for treatment they have spent more than 30 years describing, understanding and diagnosing the most common hereditary form of stroke, CADASIL. For this, the four French neuroscientists are now receiving the world's most valuable prize for brain research – the Lundbeck Foundation Brain Prize, worth 1 million euros.

BioMed Alliance - European medical experts unite to improve scientific scrutiny of evidence for approval of high-risk medical devices in the European Union

Sharing #LifeGoals has become a popular social media trend. This campaign will put a new spin on the #LifeGoals trend by seeing people instead sharing #BrainLifeGoals.

On February 7th,  2019, the EAN signed a Memorandum of Understanding (MoU) with the ERN – EURO - NMS mentioned above.

    by Professor Dafin Mureşanu       Specialists in neurology and psychiatry from Moscow and many regions of Russia  and eminent international speakers gathered in Moscow for a multidisciplinary conference on “Advances In Neuroscience And New Strategies For… Continue Reading

News from EMA The February issue of the EMA Newsletter ”Human Medicines Highlights” which includes decisions by our Scientific Committees and updates on medicines safety can be accessed here.   Note: Please be advised that EMA London offices will close… Continue Reading

Alzheimer Europe examines experiences of people from minority ethnic backgrounds with dementia, in 2018 ethics report https://www.alzheimer-europe.org/News/Alzheimer-Europe/Friday-22-February-2019-AE-examines-experiences-of-people-from-minority-ethnic-backgrounds-with-dementia-in-2018-ethics-report

On 11 March, Brain Awareness Week will kick off its 24th year of connecting brain science enthusiasts in Europe and around the world with public audiences to build curiosity and understanding about the brain.

EBC will hold the reception “Mood and Food: Exploring the gut-brain connection” in the European Parliament on the occasion of Brain Awareness Week (BAW) 2019. This year’s event, organized in cooperation with the European Dana Alliance for the Brain (EDAB)… Continue Reading

The BioMed Alliance members have produced a cartoon to raise awareness among doctors and the public on the importance of high quality and unbiased Continuing Medical Education (CME).

        by Anna Sauerbier         Development of multiple sclerosis policy report and national brain plans with a focus on MS, a European Brain Council & Health Policy Partnership 2018–2019 Joint Project https://www.braincouncil.eu/activities/news/MSpolicynarrative   A… Continue Reading

The European Medicines Agency (EMA) has been interacting with European healthcare professionals in various areas of its work since founded in 1995. As prescribers and handlers of the medicines that the Agency evaluates, healthcare professionals are key stakeholders in the… Continue Reading

18 January: Lancet commentary highlights recommendations developed by Global Alliance for Genomics and Health, Ageing and Dementia Task Team The Lancet Neurology (February 2019 edition) has published a commentary by Adrian Thorogood et al. on “Openness, inclusion, and respect in… Continue Reading